A new intravenous immunoglobulin in adult and childhood idiopathic thrombocytopenic purpura: a review.
This is a review of the work leading to the generalized use of intravenous immunoglobulins (IVIgG) in the treatment of idiopathic thrombocytopenic purpura. Much of the work performed using a reduced and alkylated IVIgG is discussed. Finally, preliminary data on the results being achieved with a new non-modified IVIgG in idiopathic thrombocytopenic purpura (ITP) is dealt with in two studies involving a total of 42 patients.
D000328:Adult; D001327:Autoimmune Diseases / Q000628:therapy*; D002648:Child; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D007262:Infusions, Intravenous; D008297:Male; D011696:Purpura, Thrombocytopenic / Q000628:therapy*
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous